drugset / Trial / NCT04286529

Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons

NCT04286529

Phase 1 Terminated 17 enrolled Mayo Clinic
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this research is to study the effects of 1,25(OH)2 D3 (a prescription form of active Vitamin D) on muscle strength and insulin secretion by the pancreas and glucose utilization by skeletal muscle.

Timeline

Start
2020-10-01
Primary completion
2021-05-28
Completion
2021-05-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcitriol Small molecule 0.25 ug Oral

Indications